By Herald Staff Verastem Inc., a Cambridge startup led by serial biotech entrepreneur Christoph Westphal, has filed for an initial public offering of stock. The cancer drug developer is looking to raise up to $50 million, according to a filing today ... Cambridge biotech Verastem files for $50M IPO
Wednesday, November 2, 2011
Cambridge biotech Verastem files for $50M IPO
By Herald Staff Verastem Inc., a Cambridge startup led by serial biotech entrepreneur Christoph Westphal, has filed for an initial public offering of stock. The cancer drug developer is looking to raise up to $50 million, according to a filing today ... Cambridge biotech Verastem files for $50M IPO
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment